Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Shares Outstanding (Diluted Average) (2021 - 2025)

BioAtla's Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $58.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 21.11% year-over-year to $58.8 million; the TTM value through Dec 2025 reached $58.8 million, up 21.11%, while the annual FY2025 figure was $58.8 million, 21.11% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $58.8 million in Q4 2025 per BCAB's latest filing, up from $58.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $58.8 million in Q4 2025 to a low of $33.7 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $45.9 million, with a median of $47.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 27.5% in 2023, then increased 0.79% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $34.6 million in 2021, then increased by 12.63% to $38.9 million in 2022, then increased by 22.74% to $47.8 million in 2023, then rose by 1.67% to $48.6 million in 2024, then rose by 21.11% to $58.8 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Shares Outstanding (Diluted Average) are $58.8 million (Q4 2025), $58.5 million (Q3 2025), and $58.5 million (Q2 2025).